Evidence map›Paper›PMID 31059501›Full record

ArticlePLoS neglected tropical diseases2019

Hindgut microbiota in laboratory-reared and wild Triatoma infestans.

Andreea Waltmann, Alexandra C Willcox, Sujata Balasubramanian, Katty Borrini Mayori, Sandra Mendoza Guerrero, Renzo S Salazar Sanchez, Jeffrey Roach, Carlos Condori Pino, Robert H Gilman, Caryn Bern and 4 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Ecological origin and naturalCurrent research in parasitology & vector-borne diseases · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pathogens (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Effect ofInsects · 2024
    Article
  16. Enterobacteriaceae as a Key Indicator of Huanglongbing Infection inInternational journal of molecular sciences · 2024
    Article
  17. Interaction ofMicroorganisms · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Andreea WaltmannInstitute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID 0000-0001-9219-6570
Alexandra C WillcoxDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Sujata BalasubramanianDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Katty Borrini MayoriZoonotic Disease Research Laboratory, Unidad de Una Salud, Universidad Peruana Cayetano Heredia, Arequipa, Perú.
Sandra Mendoza GuerreroDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID 0000-0001-9959-247X
Renzo S Salazar SanchezZoonotic Disease Research Laboratory, Unidad de Una Salud, Universidad Peruana Cayetano Heredia, Arequipa, Perú.ORCID 0000-0002-5127-0479
Jeffrey RoachMicrobiome Core Facility, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Carlos Condori PinoZoonotic Disease Research Laboratory, Unidad de Una Salud, Universidad Peruana Cayetano Heredia, Arequipa, Perú.
Robert H GilmanDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Caryn BernDepartment of Epidemiology and Biostatistics, School of Medicine, University of California-San Francisco, San Francisco, California, United States of America.
Jonathan J JulianoDivision of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Michael Z LevyDepartment of Biostatistics, Epidemiology & Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Steven R MeshnickInstitute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Natalie M BowmanDivision of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Funding

Predictors of cardiomyopathy progression in a Chagas disease cohort in BoliviaR01AI107028 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2014 to 2023
$6.6M
Disrupting Vector-borne Disease Transmission in Complex Urban EnvironmentsR01AI101229 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LEVY, MICHAEL Z · 2013 to 2017
$3.1M
The pathogenesis of T. cruzi in HIV-infected persons in BoliviaK23AI113197 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOWMAN, NATALIE MCCARTER · 2014 to 2018
$878k
NIAID NIH HHS K23 AI113197NIAID NIH HHS R01 AI101229NIAID NIH HHS R01 AI107028
6 · The paper itself

Abstract

Triatomine vectors transmit Trypanosoma cruzi, the etiological agent of Chagas disease in humans. Transmission to humans typically occurs when contaminated triatomine feces come in contact with the bite site or mucosal membranes. In the Southern Cone of South America, where the highest burden of disease exists, Triatoma infestans is the principal vector for T. cruzi. Recent studies of other vector-borne illnesses have shown that arthropod microbiota influences the ability of infectious agents to colonize the insect vector and transmit to the human host. This has garnered attention as a potential control strategy against T. cruzi, as vector control is the main tool of Chagas disease prevention. Here we characterized the microbiota in T. infestans feces of both wild-caught and laboratory-reared insects and examined the relationship between microbial composition and T. cruzi infection using highly sensitive high-throughput sequencing technology to sequence the V3-V4 region of the 16S ribosomal RNA gene on the MiSeq Illumina platform. We collected 59 wild (9 with T. cruzi infection) and 10 lab-reared T. infestans (4 with T. cruzi infection) from the endemic area of Arequipa, Perú. Wild T. infestans had greater hindgut bacterial diversity than laboratory-reared bugs. Microbiota of lab insects comprised a subset of those identified in their wild counterparts, with 96 of the total 124 genera also observed in laboratory-reared insects. Among wild insects, variation in bacterial composition was observed, but time and location of collection and development stage did not explain this variation. T. cruzi infection in lab insects did not affect α- or β-diversity; however, we did find that the β-diversity of wild insects differed if they were infected with T. cruzi and identified 10 specific taxa that had significantly different relative abundances in infected vs. uninfected wild T. infestans (Bosea, Mesorhizobium, Dietzia, and Cupriavidus were underrepresented in infected bugs; Sporosarcina, an unclassified genus of Porphyromonadaceae, Nestenrenkonia, Alkalibacterium, Peptoniphilus, Marinilactibacillus were overrepresented in infected bugs). Our findings suggest that T. cruzi infection is associated with the microbiota of T. infestans and that inferring the microbiota of wild T. infestans may not be possible through sampling of T. infestans reared in the insectary.

Indexed as

MicrobiotaAnimalsBacteriaChagas DiseaseDNA, BacterialFecesGastrointestinal TractHumansInsect VectorsLaboratoriesPhylogenyRNA, Ribosomal, 16STriatomaTrypanosoma cruziDNA, BacterialRNA, Ribosomal, 16S

Identifiers

PMID31059501
PMCPMC6522061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.